GLP-1 receptor agonists show promise in alleviating depressive symptoms in patients with type 2 diabetes, offering a potential dual benefit in treatment.
Ashar Akhtar, PharmD Candidate
Advertisement
Articles by Ashar Akhtar, PharmD Candidate
Advertisement
Latest Updated Articles
Exploring the Antidepressant Potential of GLP-1 Receptor AgonistsPublished: September 10th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
Bacteria and Fungi in the Mouth Found to Drive Pancreatic Cancer Risk
2
How the FDA Is Using AI to Monitor Drug Advertising and Ensure Compliance
3
FDA Approves Lurbinectedin Combination Regimen in Extensive-Stage SCLC
4
Building an Opioid Stewardship Program in Cancer Care: Pharmacist Roles, Challenges, and Patient Safety
5
